NCT02728479 Percutaneous Transluminal Angioplasty Registry
| NCT ID | NCT02728479 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Klinik für Kardiologie, Pneumologie und Angiologie |
| Condition | Percutaneous Transluminal Angioplasty |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2014-01 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2014-01 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease. The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing PTA Exclusion Criteria: * \< 18 years
Contact & Investigator
Christian Heiss, MD
PRINCIPAL INVESTIGATOR
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Frequently Asked Questions
Who can join the NCT02728479 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Percutaneous Transluminal Angioplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02728479 currently recruiting?
Yes, NCT02728479 is actively recruiting participants. Contact the research team at christian.heiss@med.uni-duesseldorf.de for enrollment information.
Where is the NCT02728479 trial being conducted?
This trial is being conducted at Düsseldorf, Germany.
Who is sponsoring the NCT02728479 clinical trial?
NCT02728479 is sponsored by Klinik für Kardiologie, Pneumologie und Angiologie. The principal investigator is Christian Heiss, MD at Division of Cardiology, Pulmonary Disease and Vascular Medicine. The trial plans to enroll 1,000 participants.